Climb Bio, Inc. (CLYM) Misses Q1 EPS by 16c

Climb Bio, Inc. (NASDAQ: CLYM) reported Q1 EPS of ($0.31), $0.16 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Adecoagro S.A. (AGRO) Misses Q2 EPS by 63c
• Ryman Hospitality prices $700M in notes to fund Orlando acquisition